Department of Emergency Medicine, AZ St-Dimpna, J-B Stessensstraat 2, 2440, Geel, Belgium.
Department of Critical care Medicine and anesthesiology, AZ St-Dimpna, Geel, Belgium.
J Clin Monit Comput. 2021 Dec;35(6):1299-1309. doi: 10.1007/s10877-020-00596-7. Epub 2020 Oct 6.
The COVID-19 pandemic has resulted in an increased need for ventilators. The potential to ventilate more than one patient with a single ventilator, a so-called split ventilator setup, provides an emergency solution. Our hypothesis is that ventilation can be individualized by adding a flow restrictor to limit tidal volumes, add PEEP, titrate FiO and monitor ventilation. This way we could enhance optimization of patient safety and clinical applicability. We performed bench testing to test our hypothesis and identify limitations. We performed a bench testing in two test lungs: (1) determine lung compliance (2) determine volume, plateau pressure and PEEP, (3) illustrate individualization of airway pressures and tidal volume with a flow restrictor, (4a) illustrate that PEEP can be applied and individualized (4b) create and measure intrinsic PEEP (4c and d) determine PEEP as a function of flow restriction, (5) individualization of FiO. The lung compliance varied between 13 and 27 mL/cmHO. Set ventilator settings could be applied and measured. Extrinsic PEEP can be applied except for settings with a large expiratory time. Volume and pressure regulation is possible between 70 and 39% flow restrictor valve closure. Flow restriction in the tested circuit had no effect on the other circuit or on intrinsic PEEP. FiO could be modulated individually between 0.21 and 0.8 by gradually adjusting the additional flow, and minimal affecting FiO in the other circuit. Tidal volumes, PEEP and FiO can be individualized and monitored in a bench testing of a split ventilator. In vivo research is needed to further explore the clinical limitations and outcomes, making implementation possible as a last resort ventilation strategy.
COVID-19 大流行导致对呼吸机的需求增加。通过所谓的分呼吸机设置,可以同时对一个以上的患者进行通气,从而提供紧急解决方案。我们的假设是,通过添加流量限制器来限制潮气量、增加 PEEP、滴定 FiO 并监测通气,可以实现个体化通气。这样,我们可以增强患者安全性和临床适用性的优化。我们进行了台架测试来验证我们的假设并确定限制因素。我们在两个测试肺中进行了台架测试:(1)确定肺顺应性,(2)确定容量、平台压和 PEEP,(3)说明气道压力和潮气量通过流量限制器的个体化,(4a)说明 PEEP 可以应用和个体化,(4b)创建和测量固有 PEEP,(4c 和 d)确定 PEEP 作为流量限制的函数,(5)FiO 的个体化。肺顺应性在 13 至 27 mL/cmHO 之间变化。可以应用和测量设定的呼吸机设置。可以施加外源性 PEEP,但对于呼气时间较长的设置除外。在 70%至 39%流量限制器阀关闭之间可以实现容量和压力调节。在测试的回路中,流量限制对另一个回路或固有 PEEP 没有影响。通过逐渐调整附加流量,可以将 FiO 在 0.21 至 0.8 之间进行个体化调节,而对另一个回路中的 FiO 的影响最小。在分呼吸机的台架测试中,可以实现潮气量、PEEP 和 FiO 的个体化和监测。需要进行体内研究以进一步探索临床限制和结果,以便作为最后的通气策略进行实施。